Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 2003 Oct 15;375(Pt 2):323–328. doi: 10.1042/BJ20030541

Investigating interactions of the pentraxins serum amyloid P component and C-reactive protein by mass spectrometry.

J Andrew Aquilina 1, Carol V Robinson 1
PMCID: PMC1223703  PMID: 12892563

Abstract

The oligomeric state of human SAP (serum amyloid P component) in the absence and presence of known ligands has been investigated using nanoelectrospray ionization MS. At pH 8.0, in the absence of Ca2+, SAP has been shown to consist of pentameric and decameric forms. In the presence of physiological levels of Ca2+, SAP was observed to exist primarily as a pentamer, reflecting its in vivo state. dAMP was shown not only to promote decamerization, but also to lead to decamer stacking involving up to 30 monomers. A mechanism for this finding is proposed. CRP (C-reactive protein), a pentraxin closely related to SAP, exists as a pentamer in the presence or absence of Ca2+. Pentamers of CRP and SAP were shown to form mixed decamers in Ca2+-free buffer; however, in the presence of Ca2+, this interaction was not observed. Furthermore, no exchange of monomeric subunits was observed between the SAP and CRP oligomers, suggesting a remarkable stability of the individual pentameric complexes.

Full Text

The Full Text of this article is available as a PDF (127.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashton A. W., Boehm M. K., Gallimore J. R., Pepys M. B., Perkins S. J. Pentameric and decameric structures in solution of serum amyloid P component by X-ray and neutron scattering and molecular modelling analyses. J Mol Biol. 1997 Sep 26;272(3):408–422. doi: 10.1006/jmbi.1997.1271. [DOI] [PubMed] [Google Scholar]
  2. Baltz M. L., De Beer F. C., Feinstein A., Pepys M. B. Calcium-dependent aggregation of human serum amyloid P component. Biochim Biophys Acta. 1982 Feb 18;701(2):229–236. doi: 10.1016/0167-4838(82)90118-2. [DOI] [PubMed] [Google Scholar]
  3. Bickerstaff M. C., Botto M., Hutchinson W. L., Herbert J., Tennent G. A., Bybee A., Mitchell D. A., Cook H. T., Butler P. J., Walport M. J. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat Med. 1999 Jun;5(6):694–697. doi: 10.1038/9544. [DOI] [PubMed] [Google Scholar]
  4. Emsley J., White H. E., O'Hara B. P., Oliva G., Srinivasan N., Tickle I. J., Blundell T. L., Pepys M. B., Wood S. P. Structure of pentameric human serum amyloid P component. Nature. 1994 Jan 27;367(6461):338–345. doi: 10.1038/367338a0. [DOI] [PubMed] [Google Scholar]
  5. Hamazaki H. Amyloid P component promotes aggregation of Alzheimer's beta-amyloid peptide. Biochem Biophys Res Commun. 1995 Jun 15;211(2):349–353. doi: 10.1006/bbrc.1995.1819. [DOI] [PubMed] [Google Scholar]
  6. Hamazaki H. Ca(2+)-dependent binding of human serum amyloid P component to Alzheimer's beta-amyloid peptide. J Biol Chem. 1995 May 5;270(18):10392–10394. doi: 10.1074/jbc.270.18.10392. [DOI] [PubMed] [Google Scholar]
  7. Hohenester E., Hutchinson W. L., Pepys M. B., Wood S. P. Crystal structure of a decameric complex of human serum amyloid P component with bound dAMP. J Mol Biol. 1997 Jun 20;269(4):570–578. doi: 10.1006/jmbi.1997.1075. [DOI] [PubMed] [Google Scholar]
  8. Hutchinson W. L., Hohenester E., Pepys M. B. Human serum amyloid P component is a single uncomplexed pentamer in whole serum. Mol Med. 2000 Jun;6(6):482–493. [PMC free article] [PubMed] [Google Scholar]
  9. Janciauskiene S., García de Frutos P., Carlemalm E., Dahlbäck B., Eriksson S. Inhibition of Alzheimer beta-peptide fibril formation by serum amyloid P component. J Biol Chem. 1995 Nov 3;270(44):26041–26044. doi: 10.1074/jbc.270.44.26041. [DOI] [PubMed] [Google Scholar]
  10. Kushner I., Ganapathi M., Schultz D. The acute phase response is mediated by heterogeneous mechanisms. Ann N Y Acad Sci. 1989;557:19–30. doi: 10.1111/j.1749-6632.1989.tb23996.x. [DOI] [PubMed] [Google Scholar]
  11. Nettleton E. J., Sunde M., Lai Z., Kelly J. W., Dobson C. M., Robinson C. V. Protein subunit interactions and structural integrity of amyloidogenic transthyretins: evidence from electrospray mass spectrometry. J Mol Biol. 1998 Aug 21;281(3):553–564. doi: 10.1006/jmbi.1998.1937. [DOI] [PubMed] [Google Scholar]
  12. Noursadeghi M., Bickerstaff M. C., Gallimore J. R., Herbert J., Cohen J., Pepys M. B. Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen. Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14584–14589. doi: 10.1073/pnas.97.26.14584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Painter R. H., De Escallón I., Massey A., Pinteric L., Stern S. B. The structure and binding characteristics of serum amyloid protein (9.5S alpha 1-glycoprotein). Ann N Y Acad Sci. 1982;389:199–215. doi: 10.1111/j.1749-6632.1982.tb22138.x. [DOI] [PubMed] [Google Scholar]
  14. Pepys M. B., Baltz M. L. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol. 1983;34:141–212. doi: 10.1016/s0065-2776(08)60379-x. [DOI] [PubMed] [Google Scholar]
  15. Pepys M. B., Baltz M. L., de Beer F. C., Dyck R. F., Holford S., Breathnach S. M., Black M. M., Tribe C. R., Evans D. J., Feinstein A. Biology of serum amyloid P component. Ann N Y Acad Sci. 1982;389:286–298. doi: 10.1111/j.1749-6632.1982.tb22144.x. [DOI] [PubMed] [Google Scholar]
  16. Pepys M. B., Butler P. J. Serum amyloid P component is the major calcium-dependent specific DNA binding protein of the serum. Biochem Biophys Res Commun. 1987 Oct 14;148(1):308–313. doi: 10.1016/0006-291x(87)91111-9. [DOI] [PubMed] [Google Scholar]
  17. Pepys M. B., Dash A. C., Markham R. E., Thomas H. C., Williams B. D., Petrie A. Comparative clinical study of protein SAP (amyloid P component) and C-reactive protein in serum. Clin Exp Immunol. 1978 Apr;32(1):119–124. [PMC free article] [PubMed] [Google Scholar]
  18. Pepys M. B., Herbert J., Hutchinson W. L., Tennent G. A., Lachmann H. J., Gallimore J. R., Lovat L. B., Bartfai T., Alanine A., Hertel C. Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis. Nature. 2002 May 16;417(6886):254–259. doi: 10.1038/417254a. [DOI] [PubMed] [Google Scholar]
  19. Pepys M. B., Rademacher T. W., Amatayakul-Chantler S., Williams P., Noble G. E., Hutchinson W. L., Hawkins P. N., Nelson S. R., Gallimore J. R., Herbert J. Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure. Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5602–5606. doi: 10.1073/pnas.91.12.5602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Rifai N., Ridker P. M. High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem. 2001 Mar;47(3):403–411. [PubMed] [Google Scholar]
  21. Robinson Carol V. Protein complexes take flight. Nat Struct Biol. 2002 Jul;9(7):505–506. doi: 10.1038/nsb0702-505. [DOI] [PubMed] [Google Scholar]
  22. Rostom A. A., Fucini P., Benjamin D. R., Juenemann R., Nierhaus K. H., Hartl F. U., Dobson C. M., Robinson C. V. Detection and selective dissociation of intact ribosomes in a mass spectrometer. Proc Natl Acad Sci U S A. 2000 May 9;97(10):5185–5190. doi: 10.1073/pnas.97.10.5185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Sobott Frank, Benesch Justin L. P., Vierling Elizabeth, Robinson Carol V. Subunit exchange of multimeric protein complexes. Real-time monitoring of subunit exchange between small heat shock proteins by using electrospray mass spectrometry. J Biol Chem. 2002 Jul 23;277(41):38921–38929. doi: 10.1074/jbc.M206060200. [DOI] [PubMed] [Google Scholar]
  24. Swanson S. J., Christner R. B., Mortensen R. F. Human serum amyloid P-component (SAP) selectively binds to immobilized or bound forms of C-reactive protein (CRP). Biochim Biophys Acta. 1992 Dec 28;1160(3):309–316. doi: 10.1016/0167-4838(92)90093-s. [DOI] [PubMed] [Google Scholar]
  25. Sørensen I. J., Andersen O., Nielsen E. H., Svehag S. E. Native human serum amyloid P component is a single pentamer. Scand J Immunol. 1995 Mar;41(3):263–267. doi: 10.1111/j.1365-3083.1995.tb03562.x. [DOI] [PubMed] [Google Scholar]
  26. Tennent G. A., Lovat L. B., Pepys M. B. Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis. Proc Natl Acad Sci U S A. 1995 May 9;92(10):4299–4303. doi: 10.1073/pnas.92.10.4299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. de Beer F. C., Baltz M. L., Holford S., Feinstein A., Pepys M. B. Fibronectin and C4-binding protein are selectively bound by aggregated amyloid P component. J Exp Med. 1981 Oct 1;154(4):1134–1139. doi: 10.1084/jem.154.4.1134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. de Beer F. C., Soutar A. K., Baltz M. L., Trayner I. M., Feinstein A., Pepys M. B. Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein. J Exp Med. 1982 Jul 1;156(1):230–242. doi: 10.1084/jem.156.1.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. van Berkel W. J., van den Heuvel R. H., Versluis C., Heck A. J. Detection of intact megaDalton protein assemblies of vanillyl-alcohol oxidase by mass spectrometry. Protein Sci. 2000 Mar;9(3):435–439. doi: 10.1110/ps.9.3.435. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES